Masimo Co. (NASDAQ:MASI) Holdings Lowered by Advisors Asset Management Inc.

Advisors Asset Management Inc. trimmed its stake in shares of Masimo Co. (NASDAQ:MASIGet Rating) by 52.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,433 shares of the medical equipment provider’s stock after selling 3,816 shares during the quarter. Advisors Asset Management Inc.’s holdings in Masimo were worth $449,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Center for Financial Planning Inc. bought a new stake in shares of Masimo in the 1st quarter worth approximately $29,000. Meeder Asset Management Inc. raised its holdings in shares of Masimo by 61.3% in the 2nd quarter. Meeder Asset Management Inc. now owns 221 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 84 shares in the last quarter. Parallel Advisors LLC raised its holdings in shares of Masimo by 38.8% in the 2nd quarter. Parallel Advisors LLC now owns 365 shares of the medical equipment provider’s stock worth $48,000 after purchasing an additional 102 shares in the last quarter. Archer Investment Corp raised its holdings in shares of Masimo by 62.2% in the 2nd quarter. Archer Investment Corp now owns 391 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 150 shares in the last quarter. Finally, EverSource Wealth Advisors LLC bought a new stake in shares of Masimo in the 2nd quarter worth approximately $61,000. 93.31% of the stock is currently owned by institutional investors.

Masimo Stock Performance

Shares of MASI opened at $141.46 on Friday. The company’s 50 day moving average price is $137.02 and its 200 day moving average price is $139.27. Masimo Co. has a 52 week low of $108.89 and a 52 week high of $305.21. The company has a market capitalization of $7.44 billion, a PE ratio of 46.84 and a beta of 0.87. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.28 and a current ratio of 2.12.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on MASI shares. Jefferies Financial Group started coverage on shares of Masimo in a research report on Wednesday, October 12th. They issued a “buy” rating and a $180.00 target price on the stock. Needham & Company LLC lifted their target price on shares of Masimo from $163.00 to $179.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Piper Sandler dropped their target price on shares of Masimo from $150.00 to $135.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 9th. Wolfe Research raised shares of Masimo from a “peer perform” rating to an “outperform” rating and set a $165.00 target price on the stock in a research report on Thursday, September 15th. Finally, Stifel Nicolaus lifted their target price on shares of Masimo from $162.00 to $172.00 and gave the stock a “buy” rating in a research report on Monday, September 12th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Masimo currently has a consensus rating of “Moderate Buy” and a consensus target price of $190.29.

Insider Activity at Masimo

In related news, CEO Joe E. Kiani acquired 7,784 shares of the stock in a transaction that occurred on Friday, November 11th. The shares were purchased at an average cost of $129.27 per share, with a total value of $1,006,237.68. Following the completion of the transaction, the chief executive officer now owns 7,784 shares of the company’s stock, valued at approximately $1,006,237.68. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Masimo news, CEO Joe E. Kiani bought 31,994 shares of the firm’s stock in a transaction on Monday, November 14th. The stock was bought at an average cost of $123.99 per share, with a total value of $3,966,936.06. Following the completion of the transaction, the chief executive officer now directly owns 39,778 shares of the company’s stock, valued at approximately $4,932,074.22. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Joe E. Kiani bought 7,784 shares of the firm’s stock in a transaction on Friday, November 11th. The stock was acquired at an average cost of $129.27 per share, with a total value of $1,006,237.68. Following the completion of the transaction, the chief executive officer now directly owns 7,784 shares of the company’s stock, valued at $1,006,237.68. The disclosure for this purchase can be found here. 9.70% of the stock is currently owned by insiders.

Masimo Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Further Reading

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIGet Rating).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.